17 Jun 2008 to 20 Jun 2008
MORE EVENTS»
Fusion Antibodies will be exhibiting at BIO 2008 in San Diego, US
Sub pages
Partnering
Discovery Strategy
Fusion Antibodies use a combination of microarray and proteomic techniques to discover and identify new targets. Proof of concept reagents are produced using our FETTM platform. After successful in vivo and in vitro validation our lead drug candidates are humanized in preparation for Phase1 clinical trials.
